Journal Information
Vol. 100. Issue 1.
Pages 81-82 (01 January 2024)
Vol. 100. Issue 1.
Pages 81-82 (01 January 2024)
Images in Paediatrics
Full text access
Multiple ephelides: Just freckles?
Efélides múltiples: ¿solo pecas?
María Cristina Pradillo Martín
Corresponding author

Corresponding author.
, Ángeles Porcel Jurado, Ana Nevado Jiménez, Eduardo Antonio Torres Magno
Centro de Salud El Cónsul, Distrito Sanitario Málaga, Málaga, Spain
This item has received
Article information
Full Text
Download PDF
Figures (2)
Full Text

We present the case of a boy aged 20 months, of European ancestry, born to consanguineous parents (second cousins). From 1 year post birth, he developed multiple ephelides clustered in areas exposed to sunlight, chiefly in the face (Figs. 1 and 2), leading to the clinical diagnosis of xeroderma pigmentosum (XP). The diagnosis was confirmed with the detection of the homozygous pathogenic variant c.1643_1644delTG (p.Val548Alafs*25) in the XPC gene, associated with XP type C. Both parents, who were asymptomatic, carried the variant in a single allele. There was no evidence of ophthalmological or neurologic involvement. The examination of the hair with polarised light microscopy did not reveal abnormalities.

Figure 1.

Face of the patient at age 2 years.

Figure 2.

Lesions caused by expossure to sunlight visualised with UV light (courtesy of Javier del Boz González).


Xeroderma pigmentosum XP is a rare hereditary skin disease (prevalence, 1–2.3/1 000 000) characterised by extreme cellular sensitivity to ultraviolet radiation associated with changes in genes involved in DNA repair.1 It has an autosomal recessive pattern of inheritance, and there are 8 subtypes: XP type A through G and XP variant.2,3 It manifests with multiple ephelides from age 1–2 years in areas exposed to sunlight, sunburn after short exposures, premature skin ageing, increased risk of skin cancer (squamous cell/basal cell carcinoma, melanoma) and ophthalmological and neurologic abnormalities.1–3 The latter are infrequent in XP group C, which is most common in Spain.2 It can be diagnosed based on clinical features and confirmed with molecular methods.3 The goal of management, based on lifelong avoidance of exposure to ultraviolet radiation, is the prevention and early detection of skin cancer from a young age.1,3

S. Rivera Peñaranda, C. Ortuño Gil, M. Vera Lorente, R. Iniesta Mompeán, I. Cascales Barceló.
Xeroderma pigmentoso. Dos casos más en España.
An Pediatr, 58 (2003), pp. 395-403
J.O. Black.
Xeroderma pigmentosum.
Head Neck Pathol, 10 (2016), pp. 139-144
J. Lehmann, C. Seebode, M.C. Martens, S. Emmert.
Xeroderma pigmentosum – Facts and perspectives.
Anticancer Res, 38 (2018), pp. 1159-1164
Copyright © 2023. Asociación Española de Pediatría
Anales de Pediatría (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?